Augmentation therapy with aripiprazole in treatment-resistant ocd in childhood: which SSRI to choose, fluoxetine or sertraline?

Basit Öğe Kaydı
dc.contributor.authorArdic, U. Akyol
dc.contributor.authorErcan, E.
dc.contributor.authorYuce, D.
dc.contributor.authorErcan, E.
dc.contributor.authorDurak, S.
dc.contributor.authorKutlu, A.
dc.date.accessioned2019-10-27T20:24:09Z
dc.date.available2019-10-27T20:24:09Z
dc.date.issued2015
dc.departmentEge Üniversitesien_US
dc.identifier.endpageS183en_US
dc.identifier.issn1018-8827
dc.identifier.issn1435-165X
dc.identifier.startpageS183en_US
dc.identifier.urihttps://hdl.handle.net/11454/42098
dc.identifier.volume24en_US
dc.identifier.wosWOS:000367823900486en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofEuropean Child & Adolescent Psychiatryen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAripiprazoleen_US
dc.subjectAugmentationen_US
dc.subjectObsessive-compulsive disorderen_US
dc.titleAugmentation therapy with aripiprazole in treatment-resistant ocd in childhood: which SSRI to choose, fluoxetine or sertraline?en_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu